Vivonics is proud to announce that we have been awarded a $2 million contract from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for Phase II development of our wearable blood alcohol content monitor. Led by Dr. Michele Pierro, this effort aims to provide a non-invasive and discreet method of accurately measuring blood alcohol concentration without the disadvantages and social stigma of other commonly used methods. This program will provide an unobtrusive way for those undergoing treatment for alcohol abuse, as well as their healthcare providers, to monitor and track alcohol use to better inform treatment options and measure progress. It will also give researchers a new tool to better understand the effects of alcohol use and abuse and the progression of alcohol abuse disorders.

Thanks to the Vivonics team for making this happen!